Julie Daves
2023
In 2023, Julie Daves earned a total compensation of $533.4K as SVP, Clinical Development Operations at DiaMedica Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $91,657 |
|---|---|
| Option Awards | $118,309 |
| Salary | $306,754 |
| Other | $16,650 |
| Total | $533,370 |
Daves received $306.8K in salary, accounting for 58% of the total pay in 2023.
Daves also received $91.7K in non-equity incentive plan, $118.3K in option awards and $16.7K in other compensation.
Rankings
In 2023, Julie Daves' compensation ranked 1,934th out of 2,918 executives tracked by ExecPay. In other words, Daves earned more than 33.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,934 out of 2,918 | 34th |
Division Manufacturing | 1,110 out of 1,608 | 31st |
Major group Chemicals And Allied Products | 685 out of 901 | 24th |
Industry group Drugs | 668 out of 864 | 23rd |
Industry Pharmaceutical Preparations | 478 out of 622 | 23rd |
Source: SEC filing on April 4, 2024.
Daves' colleagues
We found three more compensation records of executives who worked with Julie Daves at DiaMedica Therapeutics in 2023.